News
The Pistoia Alliance launches user experience maturity model for life sciences
The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life science and healthcare R&D, has launched a free...
Clinical Trials
Bharat Biotech underplays adverse event in Covaxin Phase 1 trial as start date for Phase 3 nears
Bharat Biotech, during its phase 1 trials, experienced an adverse event in a volunteer that it did not promptly admit to the public. As...
Press Releases
Roche announces FDA approval of Xofluza for the prevention of influenza following contact with an infected person
Roche announced that the U.S. FDA has approved a supplemental New Drug Application (sNDA) for Xofluza® (baloxavir marboxil) as a treatment to prevent influenza...
News
Oxford & AstraZeneca Covid-19 vaccine up to 90% effective, data shows
Preliminary results from an interim analysis of clinical trials of the ChAdOx1 nCoV-19 candidate show the vaccine is on average 70.4% effective at preventing...
Packaging & Labelling
Pelican BioThermal Expands Deep Frozen Product Range to Meet COVID-19 Vaccine Shipping Requirements
Pelican BioThermal, the global name in temperature controlled packaging, announces deep frozen temperature controlled packaging options with temperature ranges of minus 80 degrees Celsius...
News
Chinese company seeks permission to launch covid vaccine for public use
A leading Chinese vaccine developer has applied for authorization to bring its Covid-19 shot to the market, seeking to get a jump on Western...
News
Nearly a million receive injection of Sinopharm-developed vaccine, no serious adverse reactions
Vaccines developed by Chinese pharmaceutical company Sinopharm Group have now been used on nearly one million people, with no serious adverse reactions reported, and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read